Alector IPO Banks $176M to Test Alzheimer's Drugs in Clinical Trials Skip to main content
All Thayer News

Alector IPO Banks $176M to Test Alzheimer's Drugs in Clinical Trials

  |   Xconomy

For contacts and other media information visit our Media Resources page.